Abstract
We were challenged and delighted when Dr. Sharon Solomon, guest editor of this Retina Supplement, invited us to reminisce about caring for patients with common retinal disorders before there was access to the diagnostic and therapeutic tools that are readily available today. We agreed to confine our remarks to 3 common, but serious, conditions: age-related macular degeneration (Dr. Fine), diabetic retinopathy (Dr. Goldberg), and retinal detachment (Dr. Tasman). Each of us completed our ophthalmology training about half a century ago. At that time, a patient who received any 1 of the 3 diagnoses was at considerable risk of severe and irreversible loss of vision. Most readers today will have little if any experience in evaluating and treating such patients without access to a plethora of diagnostic and therapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical coherence tomography, ophthalmic ultrasound, angioinhibitory drugs, vitrectomy, intraocular gases, and many others. We are both pleased and privileged that each of us has practiced our profession long enough to enjoy what the enormous technological developments of the past half century, as described in this article, have meant for our patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S64-S77 |
| Journal | Ophthalmology |
| Volume | 123 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment : Personal Reminiscences. / Fine, Stuart L.; Goldberg, Morton F; Tasman, William.
In: Ophthalmology, Vol. 123, No. 10, 01.10.2016, p. S64-S77.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment
T2 - Personal Reminiscences
AU - Fine, Stuart L.
AU - Goldberg, Morton F
AU - Tasman, William
PY - 2016/10/1
Y1 - 2016/10/1
N2 - We were challenged and delighted when Dr. Sharon Solomon, guest editor of this Retina Supplement, invited us to reminisce about caring for patients with common retinal disorders before there was access to the diagnostic and therapeutic tools that are readily available today. We agreed to confine our remarks to 3 common, but serious, conditions: age-related macular degeneration (Dr. Fine), diabetic retinopathy (Dr. Goldberg), and retinal detachment (Dr. Tasman). Each of us completed our ophthalmology training about half a century ago. At that time, a patient who received any 1 of the 3 diagnoses was at considerable risk of severe and irreversible loss of vision. Most readers today will have little if any experience in evaluating and treating such patients without access to a plethora of diagnostic and therapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical coherence tomography, ophthalmic ultrasound, angioinhibitory drugs, vitrectomy, intraocular gases, and many others. We are both pleased and privileged that each of us has practiced our profession long enough to enjoy what the enormous technological developments of the past half century, as described in this article, have meant for our patients.
AB - We were challenged and delighted when Dr. Sharon Solomon, guest editor of this Retina Supplement, invited us to reminisce about caring for patients with common retinal disorders before there was access to the diagnostic and therapeutic tools that are readily available today. We agreed to confine our remarks to 3 common, but serious, conditions: age-related macular degeneration (Dr. Fine), diabetic retinopathy (Dr. Goldberg), and retinal detachment (Dr. Tasman). Each of us completed our ophthalmology training about half a century ago. At that time, a patient who received any 1 of the 3 diagnoses was at considerable risk of severe and irreversible loss of vision. Most readers today will have little if any experience in evaluating and treating such patients without access to a plethora of diagnostic and therapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical coherence tomography, ophthalmic ultrasound, angioinhibitory drugs, vitrectomy, intraocular gases, and many others. We are both pleased and privileged that each of us has practiced our profession long enough to enjoy what the enormous technological developments of the past half century, as described in this article, have meant for our patients.
UR - http://www.scopus.com/inward/record.url?scp=84992646925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992646925&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2016.04.058
DO - 10.1016/j.ophtha.2016.04.058
M3 - Article
C2 - 27664288
AN - SCOPUS:84992646925
VL - 123
SP - S64-S77
JO - Ophthalmology
JF - Ophthalmology
SN - 0161-6420
IS - 10
ER -